Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial.

Murray, Joseph A; Wassaf, Dina; Dunn, Karen; Arora, Samir; Winkle, Peter; Stacey, Helen; Cooper, Simon; Goldstein, Kaela E; Manchanda, Rajesh; Kontos, Stephan; Grebe, Kristie M

Murray, Joseph A; Wassaf, Dina; Dunn, Karen; Arora, Samir; Winkle, Peter; Stacey, Helen; Cooper, Simon; Goldstein, Kaela E; Manchanda, Rajesh; Kontos, Stephan; Grebe, Kristie M.

Affiliation

Murray JA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Wassaf D; Anokion, Cambridge, MA, USA.
Dunn K; North Carolina Clinical Research, Raleigh, NC, USA.
Arora S; Aventiv Research, Columbus, OH, USA.
Winkle P; Anaheim Clinical Trials, Anaheim, CA, USA.
Stacey H; Diablo Clinical Research, Walnut Creek, CA, USA.
Cooper S; Anokion, Cambridge, MA, USA.
Goldstein KE; Anokion, Cambridge, MA, USA.
Manchanda R; Anokion, Cambridge, MA, USA.
Kontos S; Anokion, Cambridge, MA, USA.
Grebe KM; Anokion, Cambridge, MA, USA. Electronic address: kristie.grebe@anokion.com.

Lancet Gastroenterol Hepatol ; 8(8): 735-747, 2023 Aug.

Article de En | MEDLINE | ID: mdl-37329900

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie coeliaque Type d'étude: Clinical_trials Limites: Adult / Humans Langue: En Journal: Lancet Gastroenterol Hepatol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google